Rapport Therapeutics Inc
NASDAQ:RAPP

Watchlist Manager
Rapport Therapeutics Inc Logo
Rapport Therapeutics Inc
NASDAQ:RAPP
Watchlist
Price: 10.62 USD -4.32% Market Closed
Market Cap: 387.6m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+8%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

RAPP Price Targets Summary
Rapport Therapeutics Inc

Wall Street analysts forecast RAPP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RAPP is 35.7 USD with a low forecast of 28.28 USD and a high forecast of 44.1 USD.

RAPP Lowest Forecast
Wall Street Target
28.28 USD
166% Upside
RAPP Average Forecast
Wall Street Target
35.7 USD
236% Upside
RAPP Highest Forecast
Wall Street Target
44.1 USD
315% Upside
Lowest
Price Target
28.28 USD
166% Upside
Average
Price Target
35.7 USD
236% Upside
Highest
Price Target
44.1 USD
315% Upside
Rapport Therapeutics Inc Competitors:
Price Targets
PAHC
Phibro Animal Health Corp
8% Upside
E
ENZY
Enzymatica AB (publ)
13% Upside
ITCI
Intra-Cellular Therapies Inc
1% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
24% Downside
PAHC
Phibro Animal Health Corp
8% Upside
E
ENZY
Enzymatica AB (publ)
13% Upside
ITCI
Intra-Cellular Therapies Inc
1% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
24% Downside
4568
Daiichi Sankyo Co Ltd
75% Upside
B
300558
Betta Pharmaceuticals Co Ltd
13% Upside
A
AETHER
Aether Industries Ltd
31% Upside
C
CLN
Celon Pharma SA
9% Upside

Revenue
Forecast

Revenue Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Rapport Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
RAPP intrinsic value, competitors valuation, and company profile.
DCF Valuation
RAPP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RAPP stock valuation using valuation multiples.
Wall Street Estimates
RAPP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RAPP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RAPP's stock price target?
Price Target
35.7 USD

According to Wall Street analysts, the average 1-year price target for RAPP is 35.7 USD with a low forecast of 28.28 USD and a high forecast of 44.1 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 249,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.